New Delhi, Sept. 27 -- Fortis Healthcare said on 27 September that it had no involvement in the ongoing legal dispute between Daiichi Sankyo and the Singh Brothers, stating that it was a "complete stranger" to the matter and played no part in the alleged diversion of the erstwhile promoters' shareholding.

In an exchange filing on Sunday, the company said it had no control over the transfer of shares by its erstwhile promoters, who owned the shares. It added that it did not receive any money or proceeds from the sale or dilution of the former promoters' shareholding.

The company further clarified that after the Singh Brothers' shareholding fell below 1% and they resigned from the Board of Directors by March 2018, institutional shareholde...